Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples